Emergent Reveals Document Requests from Federal and State Law Enforcement, Regulatory Agencies
Emergent BioSolutions, which botched 75 million doses of the Johnson & Johnson (J&J) COVID-19 vaccine, has said publicly for the first time that it has gotten records requests from a slew of federal investigators related to its COVID-19 contracts.
Emergent didn’t detail the type of documents requested but listed the revelation under the “Securities Litigation” section of the company’s quarterly report to the Securities and Exchange Commission.
Emergent said that it is “producing and has produced documents as required in response and will continue to cooperate with these government inquiries.”
Rockville, Md.-based Emergent had received $628 million from a federal contract to be the primary U.S. manufacturer of the J&J and AstraZeneca vaccines. But FDA inspections found that the company was repeatedly observed to have violated current good manufacturing practices, leading to cross-contamination between J&J’s and AstraZeneca’s COVID-19 vaccine.